- Home
- SUPN vs DBRG Comparison
SUPN vs DBRG Comparison
Compare SUPN & DBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- DBRG
- Stock Information
- Founded
- SUPN 2005
- DBRG 1991
- Country
- SUPN United States
- DBRG United States
- Employees
- SUPN N/A
- DBRG N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- DBRG Real Estate Investment Trusts
- Sector
- SUPN Health Care
- DBRG Real Estate
- Exchange
- SUPN Nasdaq
- DBRG Nasdaq
- Market Cap
- SUPN 2.0B
- DBRG 2.3B
- IPO Year
- SUPN 2012
- DBRG 2009
- Fundamental
- Price
- SUPN $35.66
- DBRG $11.71
- Analyst Decision
- SUPN Hold
- DBRG Strong Buy
- Analyst Count
- SUPN 1
- DBRG 8
- Target Price
- SUPN $36.00
- DBRG $17.88
- AVG Volume (30 Days)
- SUPN 285.1K
- DBRG 2.3M
- Earning Date
- SUPN 11-04-2024
- DBRG 11-01-2024
- Dividend Yield
- SUPN N/A
- DBRG 0.34%
- EPS Growth
- SUPN 130.79
- DBRG 1689.35
- EPS
- SUPN 1.07
- DBRG 0.76
- Revenue
- SUPN $651,972,000.00
- DBRG $876,649,000.00
- Revenue This Year
- SUPN $7.82
- DBRG N/A
- Revenue Next Year
- SUPN N/A
- DBRG N/A
- P/E Ratio
- SUPN $34.11
- DBRG $15.61
- Revenue Growth
- SUPN 6.79
- DBRG 680.46
- 52 Week Low
- SUPN $25.53
- DBRG $11.07
- 52 Week High
- SUPN $39.37
- DBRG $20.99
- Technical
- Relative Strength Index (RSI)
- SUPN 48.87
- DBRG 34.18
- Support Level
- SUPN $35.68
- DBRG $11.85
- Resistance Level
- SUPN $37.35
- DBRG $13.21
- Average True Range (ATR)
- SUPN 1.01
- DBRG 0.36
- MACD
- SUPN -0.18
- DBRG -0.03
- Stochastic Oscillator
- SUPN 21.65
- DBRG 8.46
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About DBRG DigitalBridge Group Inc.
DigitalBridge Group Inc is a developer of alternative asset manager dedicated to investing in digital infrastructure. The company's platform invests in and operates businesses across the digital ecosystem, including cell towers, data centers, fiber, small cells, and edge infrastructure, to provide clients with funds for digital infrastructure real estate infrastructure.